Applications Published 9 August 2000
Published: 25-Feb-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Neomycin/disaccharide water solution for enteroclysis in hepatic encephalopathy
Labruzzo, Carla; Vicidomini, Francesco 1024798*Method for treating disease-related or drug-induced dyskinesias
Warner-Lambert 1024799*Thyroxine analogues having no significant hormonal activity to treat malignant tumours
Octamer 1024800*Method fo regualting size and growth of vascularised normal tissue
Children's Medical Centre; Massachusetts Institute of Technology 1024801*Flavonoids for cystic fibrosis therapy
Children's Hospital Medical Centre of Northern California 1024803*MTP inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
Bristol-Myers Squibb 1024804*Use of coumarin derivatives for the treatment of digestive tract disorders
Bio-Monde Preparations 1024805*Use of non-immunosuppresive compounds for promoting nerve regeneration
Oregon Health Sciences 1024806*Pharmaceutical preparations containing hdrosoluble ketoprofen salts and their application
Errekapppa Euroterapici 1024808*Use of immunomodulating agents
Lauras 1024809*Method for optimising retinal and optic nerve health
Merck 1024810*Novel benzodiazepine derivatives as antiarrhythmic agents
Merck 1024811*Compsns containing lysophosphatidic acids which inhibit apoptosis and uses thereof
LXR Biotechnology 1024812*Use of sulphated oligosaccharides as inhibitors of cardiovascular diseases
The Australian National University 1024813*Use of antifungal agents for the toical treatment of fungus-induced mucositis
Ponikau, Jens 1024814*Pharmaceutical compsns for oral administration of iodine
Symbollon Corp 1024815*Kits and methods for alleviation of lower gastrointestinal disorders in human patients
Rubin, Walter; Dave, Bhavin 1024816*Method of curing AIDS with tetrasilver tetroxide molecular crystal devices
Antelman Technologies 1024818*Citrus peel extracts as inhibitor of acyl CoA-cholesterol-O-acyl-transferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall, and preventative of treating agent for hepatic diseases
Korea Institute of Science and Technology 1024819*Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterised by a pathologically underweight condition
Janus Pharmaceuticals 1024820*Novel prokaryotic polynucleotides, polypeptides and and their uses
SmithKline Beecham 1024821*Prevention and treatment of adhesion formulation
Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek 1024823*Solid disposal vaccine compsn for oral delivery
RP Scherer 1024824*Passive immunisation against (Clostridium difficile) disease
Oravax 1024826*Compsns and methods for systemic delivery of oral vaccines and therapeutic agents
Thomas Jefferson University 1024827*Novel PHES(Beta)
SmithKline Beecham 1024828*Tolerogenic fragments of natural allergens
CBF Leti 1024829*Antigen vectors in the form of multilamellar vesicles
Capsulis 1024830*Application of TNF antagonists as medicaments for treating septic diseases
Knoll 1024831*Pharmaceutical compsn containing acid addition salt of basic drugs
Farmarc Nederland 1024833*Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
Immunologic Pharmaceuticals 1024834*J-chain and analogues as epithelial cell targeting conjugates
EPIcyte Pharmaceuticals 1024835*Method of delivering genes to antigen presenting cells of the skin
Genetic Immunity 1024836*Ultrasound imaging with contrast agent targeted to microvasculature and a vasoldilator drug
Nycomed Imaging 1024837*Stable radioiodine conjugates and methods for their synthesis
Immunomedics 1024838*Reverse phase connective tissue repair compsn
Gensci OrthoBiologics 1024839*Bone substitute materials
Philips-Origen Ceramic Technology 1024840*(Alpha)-aryl-(N)-alkylnitrones and pharmaceutical compsns containing the same
Centaur Pharmaceuticals 1025079*Novel vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilisation thereof for producing medicaments
Schering 1025082*Process for stereoselective synthesis of prostacyclin derivatives
United Therapeutics Corp 1025083*Method for purifying 4-amino-piperidines
BASF 1025084*Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
Ortho-McNeil Pharmaceutical 1025085*Benzamidine derivatives as factor XA inhibitors
Merck 1025086*Substituted isoquinoline derivatives and their use as anticonvulsants
SmithKline Beecham 1025087*Imidazole derivatives and their use as farnesyl protein transferase inhibitors
AstraZeneca 1025088*Vitronectin receptor antagonists
SmithKline Beecham 1025090*Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
Krenitsky Pharmaceutical 1025091*Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
DuPont Pharmaceuticals 1025092*Substituted indan derivatives
AstraZeneca 1025094*Substituted chroman derivatives
AstraZeneca 1025095*Benzothiphenes
Eli Lilly 1025098*Bis-quaternary ammonium derivatives as neuromuscular relaxants
Gyermek, Laszlo; Lee, Chingmuh; Cho, Young-Moon 1025099*3-substituted tetrahydropyridopyrimidone derivatives, method for producing same, and their usesBASF 1025100*Naphtho-imidazo 1,2-A]pyrimidin derivatives, their preparation and their use in treating central nervous system disorders
Ortho-McNeil Pharmaceutical 1025101*Bycyclic kinase inhibitors
F Hoffman-La Roche 1025102*Novel polymorphic forms of cipamfylline
SmithKline Beecham 1025103*Condensed benzothiopyranic compounds
Pharmacia & Upjohn 1025105*Allosteric adenosine receptor modulators
Medco Research 1025106*Photochromic compounds
James Robinson 1025107*Photochromic spiro(indoline) fluoroanthenoxazine compounds
Transitions Optical 1025108*Benzoxazine derivatives, preparation and application in therapy
Sanofi-Synthelabo 1025109*Improved process for performing polynucletide separations
Transgenomic 1025113*Novel aspartame crystals and process for the preparation thereof
Yissum Research Development Company of the Hebrew University of Jerusalem 1025117*Spacer peptides and membranes containing same
Merck 1025118*Histogranin peptide and their analgesic use
University of Ottawa 1025119*Methods, kits and compsns pertaining to PNA molecular beacons
Boston Probes 1025120*Peptides capable of inhibiting the interaction between presenilins and the (beta)-amyloid peptide or its precursors
Aventis Pharma 1025121*Fibroblast growth factor with hepatocyte proliferation activity
Itoh, Nobuyuki 1025122*Method for the production of human blood cytokines
Klehr, Nikolaus 1025123*Low-toxicity human interferon-alpha analogues
Pepgen Corp; University of Florida 1025124*Aggregates of human insulin derivatives
Novo Nordisk 1025125*Purification of molecules
Genentech 1025126*